Sunday night, the final data was ready.
PentaBase is proud to present that we have completed the internal validation of our first COVID-19 product. By a great effort from the PentaBase employees, we have developed and validated our own test for diagnostics of COVID-19. Since we started, our approach has been to incorporate our own sensitive DNA-technology for improved diagnostics of Coronavirus – and we believe that we have succeeded in this. We haven’t just developed a highly sensitive test, but we have also combined three analyses in a single tube with great success. It is fantastic to be able to reduce the consumption of limiting resources, in a time where less patients are tested due to the lack of reagents (see Figure 1).
During the last week, PentaBase has been in close dialogue with collaborators regarding the expansion of the Danish test capacity. Together, we are now planning and designing an approach, which can contribute to an expansion of the tests capacity in the Danish health care system. We are currently testing and comparing PentaBases RNA-purification in the current workflow, which is used in the healthcare system.
From the beginning, our main focus in this crisis has been to increase the number of Danes that can be screened for Coronavirus in order to contain the spread and minimize the impact on human lives and society. We hope that our technology can contribute to this.
For more information:
A new (half)-face at PentaBase
Ann Zahle Andersen, previously head of Business Development at PentaBase and current co-founder and CBDO of the Fynen start-up GlyProVac, has temporarily joined our team as business development support in this very busy time.
“As the Corona shut-down slowed down the development work in the laboratories where we are housed, I found some time to step in and help out at PentaBase”– says Ann.
Ann’s role will mainly be to take the paperwork off CEO Ulf Bech Christensen’s hands, while he and the rest of the development and production teams at PentaBase work hard to deliver a COVID-19 test.
Connect with Ann on LinkedIn:
Read more about GlyProVac:
PentaBase has been named profile of the month by BioPeople – Denmark’s Life Science Cluster
Read the article here: Working to support Denmark combating the COVID-19 disease
Photo: Morten Albek
Our CEO highlights the fact that PentaBase is providing tools to fight against SARS-CoV-2:
”We have communicated broadly about our ability to help out detect COVID 19, because we have technologies and a knowledge that may support healthcare workers, scientists and patients combating the COVID-19 disease: SARS-CoV-2 oligonucleotides, SARS-CoV-2 test assay and instruments for SARS-CoV-2 detection,” Ulf B. Christensen says.
A devoted team of experts is behind PentaBase’s efforts to develop these necessary products:
“At PentaBase every single worker is highly specialised and trained in developing the assays for cancer diagnostics. The company divides the team into different specialised units, each of them experts in their area.”
Our CEO, Ulf Bech Christensen, has made the Danish Health Authority aware
of the help PentaBase can provide in the fight against COVID-19
Photo: Morten Albek
Find the articles here (in Danish):
- TV2Fyn: Fynsk virksomhed forsøger at råbe myndighederne op: -Vi kan teste for coronavirus
- TV2Fyn (Update): Sundhedsministeren Magnus Heunicke har efterfølgende ringet Ulf Bech Christensen op
- Berlingske: Myndighederne mangler testudstyr til coronavirus – Ulf Bech Christensen har en masse, men sundhedsvæsenet svarer ikke
- Nyheder24:Dansk virksomhed kan hjælpe med manglende coronatests, men kan ikke komme i kontakt med myndighederne
- Politiken: Den fynske virksomhed Pentabase vil gerne byde ind med deres testteknologi i den danske kamp mod coronavirus
As our board is international, PentaBase has canceled all physical board meetings until SARS-CoV-2 is under control and the restrictions on traveling across borders will no longer be into force. Furthermore, our weekly scientific and medical discussions with our chairman of the board are temporarily suspended. He is, of course, still paid by PentaBase and chairman of the board with the responsibilities that follow.
We are proud that he has signed up to help the Danish healthcare system as a volunteer in the fight against Coronavirus. He is a medical doctor of training.
Let’s all do our best to limit the impact of the virus outbreak. Stay healthy.